Empagliflozin R-Furanose
| Product Name | Empagliflozin R-Furanose |
|---|---|
| Alternate Names | Empagliflozin Impurities, Impurities of Empagliflozin |
| CAT No. | CS-O-14889 |
| CAS No. | 1620758-31-7 |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 450.91 g/mol |
| Mol. For. | C₂₃H₂₇ClO₇ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Empagliflozin |
| Therapeutic | Anti-Diabetic |
| Smileys | O[C@H]1[C@@H](C2=CC(CC3=CC=C(O[C@H]4CCOC4)C=C3)=C(Cl)C=C2)O[C@@]([C@H](O)CO)([H])[C@@H]1O |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Empagliflozin R-Furanose is a medication used to treat type 2 diabetes. It works by blocking a protein in the kidneys called SGLT2, which helps to remove excess glucose from the body through urine. This results in lower blood sugar levels and can also lead to weight loss. Empagliflozin R-Furanose can be taken orally once a day with or without food.
Chemically, Empagliflozin R-Furanose belongs to the class of drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. It is a white to off-white crystalline powder with a molecular weight of 450.51 g/mol. It is soluble in water and has a melting point of 232-234°C.
Empagliflozin R-Furanose is metabolized in the liver and excreted in the urine. It has a half-life of approximately 12.4 hours and reaches peak plasma concentration within 1.5 hours of ingestion. It is important to note that this medication should not be used to treat type 1 diabetes or diabetic ketoacidosis.
While Empagliflozin R-Furanose has shown to be effective in controlling blood sugar levels, it may also have some potential side effects. These can include increased risk of urinary tract infections, yeast infections, and dehydration. It is important to discuss any potential risks and benefits with a healthcare provider before starting this medication.
Get an Instant Quote
Related Compounds
Empagliflozin Iodo R-furan impurity | Empagliflozin M464 | Empagliflozin L- Glucono Diastereomer | Empagliflozin Bromo Impurity | Empagliflozin Impurity 4 | Empagliflozin Acetyl impurity | Empagliflozin Silyl Impurity | DIMETHOXY EMPAGLIFLOZIN | Empagliflozin Enantiomer Impurity | Empagliflozin Impurity 82 | Empagliflozin impurity B | Empagliflozin Impurity E | Empagliflozin Dichloro impurity | Empagliflozin Recemic mixture | Empagliflozin Destetrahydrofuran Impurity | Empagliflozin Iodo impurity | Methoxy Empagliflozin R-Furanose | Empagliflozin Impurity 40 | Empagliflozin Impurity 5 | Empagliflozin Dimer Impurity | Empagliflozin Impurity 2 | Hydroxy empagliflozin | Empagliflozin Nosyl ester hydroxy furan impurity | Empagliflozin S-Furanose | Empagliflozin Des bromomethoxy | Empagliflozin impurity C | Empagliflozin Diol impurity (S-Isomer) | Empagliflozin Open Ring Impurity | Empagliflozin alpha Isomer | Empagliflozin Impurity 26 | Empagliflozin Impurity 46 | Empagliflozin Sulfonate Impurity | Empagliflozin Impurity II | O-Destetrahydrofuran O-Pentaacetyl Empagliflozin | Empagliflozin Impurity 52 | Empagliflozin Methyl Acetate | Empagliflozin Impurity POE | Empagliflozin M468 | Empagliflozin Methoxy Intermediate | Empagliflozin impurity D | Empagliflozin Nosyl impurity | Empagliflozin MonoAcetyl Impurity | Empagliflozin Sugar Dimer | Empagliflozin Methoxy impurity | Empagliflozin Enantiomer Impurity | Empagliflozin Intermediate-A | Empagliflozin Impurity 62 | Empagliflozin Impurity 50 | Empagliflozin impurity A |